期刊文献+

维生素D及其受体在强直性脊柱炎患者中的表达及其临床意义

Clinical significance of vitamin D and vitamin D receptor in patients with ankylosing spondylitis
下载PDF
导出
摘要 目的:研究AS患者PBMC维生素D受体(VDR)mRNA的表达及血清25-羟维生素D3和1,25-二羟维生素D3的水平,探讨其与AS疾病活动性(BASDAI、CRP、ESR)的相关性。方法:选取26例AS患者(AS组)和年龄、性别与之相匹配的13名健康志愿者(健康对照组)。采用SYBR GreenⅠ实时荧光定量PCR检测两组受检者PBMC的VDR mRNA表达水平,应用ELISA法检测两组受检者血清25-羟维生素D3和1,25-二羟维生素D3水平,分析VDR mRNA表达水平、血清25-羟维生素D3和1,25-二羟维生素D3水平与临床相关指标(BASDAI、CRP、ESR)的关系。结果:AS患者PBMC的VDR mRNA表达水平明显高于健康对照组(P<0.01),VDR mRNA表达水平与临床相关指标(BASDAI、CRP、ESR)无关(P>0.05)。AS患者血清25-羟维生素D3、1,25-二羟维生素D3水平分别为(5.3±2.6)μg/L、(12.8±6.0)ng/L,明显低于健康对照组(14.7±3.5)μg/L、(32.6±18.5)ng/L(P均<0.01)。AS患者血清1,25-二羟维生素D3的水平与BASDAI(r=-0.481,P<0.05)、ESR(r=-0.535,P<0.01)、CRP(r=-0.674,P<0.01)均呈负相关。血清25-羟维生素D3水平与BASDAI、CRP、ESR无关(P>0.05)。结论:AS患者VDR mRNA表达水平升高,但与AS的疾病活动无关。AS患者血清1,25-二羟维生素D3水平下降,与疾病活动呈负相关,可作为AS疾病活动的指标之一。AS患者PBMC的VDR活化可能与1,25-二羟维生素D3的作用无关。 Objective: To study the expression of vitamin D receptor (VDR) mRNA in peripheral blood mono- cytes of patients with Ankylosing Spondylitis (AS) and explore the correlation between the disease activity [ eryth- roeyte sedimentation rate (ESR), C-reactive protein (CRP), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) 1 and the serum levels of 25-hydroxyvitamin D3 [25-D/25- (OH) D31 and 1,25-Dihydroxy vitamin D3 E1, 25-D/1, 25- (OH) 2D3)I in AS patients. Methods: Twentysix patients with AS and 13 age- and sex-matched healthy controls were included. Fieoll density gradient centrifugation method was used to segregate pe- ripheral blood mononuelear cells. Subsequently, total RNA in isolated monoeytes was extracted by Trizol and re- verse transeripted into eDNA. The VDR mRNA expression was examined by real time fluorescent quantitative re- verse transcriptase polymerase chain reaction (real-time qRT-PCR) and quantified using the 2-A ACT method. The serum levels of 25-D and 1, 25-D were measured by enzyme linked immuno-sorbent assay (ELISA). The eor- relations between disease activity (ESR, CRP and BASDAI) and expression of VDR mRNA and serum levels of 25-D and 1, 25-D were evaluated by spearman's rank correlation analysis. Results: The expression of VDR mRNA was significantly higher in AS group than that in control group ( P 〈 0.01 ). There was no signifieant eorrelation between expression of VDR mRNA and disease activity (BASDAI, ESR and CRP) (P 〉0. 05). The concentrations of 25-D and 1, 25-D were in AS group were significantly lower than those in healthy controls [ L vs ( 14.7±3.5 )μg/L and ( 12.8± 6.0)ng/L vs (32. 6±18.5 )ng/L, P 〈 0. 01 ]. In AS group, tive correlations were found between 1, 25-D and BASDAI ( r = - 0. 481, P 〈 0. 05 ) , ESR ( r 0. 01) and CRP (r = -0. 674, P 〈0. 01 ). However, there was no significant correlation was (5.3 ±2.6)μg/ significant nega- = -0.535, P〈 revealed between serum 25-D level and BASDAI, ESR or CRP in patients with AS (P 〉 0.05 ). Conclusion: Increased expression of VDR mRNA in AS patients has no correlation with the disease activity. The reduction of 25-D and 1, 25-D neg- atively correlated with disease activity of AS. Thus serum level of 1, 25-Dihydroxy vitamin D can be used as an in- dicator for disease activity of AS. The VDR activation may not relate to 1, 25-D.
出处 《新医学》 2011年第3期162-166,共5页 Journal of New Medicine
关键词 强直性脊柱炎 25-羟维生素D3 1 25-二羟维生素D3 维生素D受体 Vitamin D 25- (OH) D3 1, 25- (OH) 2D3 Vitamin D receptor Ankylosing spondylitis
  • 相关文献

参考文献13

  • 1TEICHERT A, ARNOLD L A, OTIENO S, et al. Quantification of the vitamin D receptor-coregulator interaction[J]. Biochemistry, 2009, 48(7): 1454-1461.
  • 2LANGE U, TEICHMANN J, STRUNK J, et al. Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis[ J ]. Osteo- porosis International, 2005, 16 (2) : 1999-2004.
  • 3OBERMAYER-PIETSCH B M, LANGE U, TAUBER G, et al. Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis [J]. Osteoporos Int, 2003, 14 (12) : 995-1000.
  • 4GARRETF S, JENKINSON T, KENNEDY L G, et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index [ J]. J Rheumatol, 1994, 21 (12) : 2286-2291.
  • 5ADORINI L, PENNA G. Control of autoimmune diseases by the vitamin D endocrine system [ J]. Nat Clin Pract Rheumatol, 2008, (4) : 404-412.
  • 6CUTOLO M, OTSA K, PAOLINO S, et al. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus[J]. Ann Rheum Dis, 2009, 68 (3) : 446-447.
  • 7OELZNER P, LEHMANN G, EIDNER T, et al. Hypercalcemia in rheumatoid arthritis: relationship with desease activity and bone metabolism [ J ]. Rheumatol Int, 2006, 26 (10): 908-915.
  • 8MERLINO L A, CURTIS J, MIKULS T R, et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Lowa Women's Health Study [J]. Arthritis Rheum, 2004, 50 (1): 72-77.
  • 9FERRARI S, RIZZOLI R, MANEN D, et al. Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: Interaction with age, dietary cal- cium, and 3 '-end region polymorphisms [J]. J Bone Miner Res, 1998, 13 (6): 925-930.
  • 10LANGE U, JUNG O, TEICHMANN J, et al. Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis[J]. Osteoporos Int, 2001, 12 (12) : 1031-1035.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部